Gutierrez, R. L., Burns, D., Lalani, T., Bennett-Carter, D., Fraser, J., Riddle, M., Connor, P., Porter, C., Troth, T., Ruck, R., Barton, J., Tilley, D. H., Kunz, A., Fairchok, M., Yun, H., Alvarez, B., Higgins, R., Mitra, I., Stewart, L., Rahman, A., Rimmer, J., Hutley, E., Swierczewski, B., Tabberer, B., & Tribble, D. (n.d.). 632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers' Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD). Open forum infectious diseases, 7, S376. http://access.bl.uk/ark:/81055/vdc_100121987975.0x00000f